Jing Zhao, M.D., Qiong Zhang, M.D., Yonggang Wang, M.D., Yanping Li, M.D.
Volume 101, Issue 2, Pages 587-594.e3, February 2014
To investigate whether bone marrow mesenchymal stem cell (BMSC) treatment could improve the regeneration of endometrium and improve the endometrial receptivity in an experimental model of thin endometrium.
Randomized, control trial, animal research.
National key laboratory.
Bone marrow mesenchymal stem cell transplantation by tail vein IV injection.
Main Outcome Measure(s):
Endometrial thickness, the expression of mark proteins for endometrial cell, and endometrial receptivity.
The endometrium was significantly thicker and the expression of cytokeratin, vimentin, integrin αγβ3, and leukemia inhibitor factor were significantly stronger compared with the control group. Some proinflammatory cytokines, such as tumor necrosis factor-α (TNF-α) messenger RNA (mRNA) and interleukin-1β mRNA, were significantly down-regulated, and anti-inflammatory cytokines, such as fibroblast growth factor-β (bFGF) mRNA and interleukin-6 mRNA, were significantly up-regulated in the experimental group compared with the control group.
The BMSCs have beneficial effect on thin endometrium, and may play a role through migration and immunomodulatory of BMSCs.
Read the full text at: http://www.fertstert.org/article/S0015-0282(13)03216-0/fulltext